Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 2, 2023
[ Thu, Mar 02nd 2023
] - WOPRAI
[ Thu, Mar 02nd 2023
] - WOPRAI
[ Thu, Mar 02nd 2023
] - WOPRAI
[ Thu, Mar 02nd 2023
] - WOPRAI
[ Thu, Mar 02nd 2023
] - WOPRAI
[ Thu, Mar 02nd 2023
] - WOPRAI
[ Thu, Mar 02nd 2023
] - WOPRAI
[ Thu, Mar 02nd 2023
] - WOPRAI
[ Thu, Mar 02nd 2023
] - WOPRAI
[ Thu, Mar 02nd 2023
] - WOPRAI
[ Thu, Mar 02nd 2023
] - WOPRAI
[ Thu, Mar 02nd 2023
] - WOPRAI
[ Thu, Mar 02nd 2023
] - WOPRAI
[ Thu, Mar 02nd 2023
] - WOPRAI
[ Thu, Mar 02nd 2023
] - WOPRAI
[ Thu, Mar 02nd 2023
] - WOPRAI
[ Thu, Mar 02nd 2023
] - WOPRAI
[ Thu, Mar 02nd 2023
] - WOPRAI
Wed, March 1, 2023
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
Ami Fadia Maintained (BCYC) at Strong Buy with Decreased Target to $67 on, Mar 1st, 2023
Ami Fadia of Needham, Maintained "Bicycle Therapeutics plc" (BCYC) at Strong Buy with Decreased Target from $72 to $67 on, Mar 1st, 2023.
Ami has made no other calls on BCYC in the last 4 months.
There are 3 other peers that have a rating on BCYC. Out of the 3 peers that are also analyzing BCYC, 0 agree with Ami's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Ami
- Tony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $55 on, Tuesday, February 28th, 2023
- Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $74 on, Monday, February 27th, 2023
- Reni Benjamin of "JMP Securities" Maintained at Buy with Decreased Target to $46 on, Wednesday, November 9th, 2022
